Showing results (411-420 of 921) with videos related to
Sort By:
Pageof 93
Anti-Cancer Drugs|November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancerT Brodowicz, R M Wolfram, W J Köstler, et al.Breast Cancer Research and Treatment|October 10, 2006
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.Journal of Cancer Research and Clinical Oncology|May 29, 2004
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot studyCatharina Wenzel, Dagmar Hussian, Rupert Bartsch, et al.Anti-Cancer Drugs|March 5, 2005
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancerCatharina Wenzel, Rupert Bartsch, Gottfried J Locker, et al.British Journal of Cancer|September 11, 2003
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatmentG Hudelist, W J Köstler, J Attems, et al.Cancer Chemotherapy and Pharmacology|November 22, 2018
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH projectMarina E Cazzaniga, E Ciruelos, A Fabi, et al.Wiener Klinische Wochenschrift|July 1, 2005
Preoperative second-line chemotherapy induces objective responses in primary breast cancerCatharina Wenzel, Gottfried J Locker, Rupert Bartsch, et al.The Breast Journal|January 29, 2013
Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancerAnna S Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.Breast Cancer Research and Treatment|January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I studyUrsula Wiedermann, C Wiltschke, J Jasinska, et al.Pageof 93